Medgadget.comAbbott XIENCE Xpedition Coronary Drug Eluting Stent Now Available in EuropeMedgadget.comAbbott XIENCE Xpedition Abbott XIENCE Xpedition Coronary Drug Eluting Stent Now Available in Europe Abbott has received European clearance and is immed…
Stents for Diabetes?dailyRxEach drug eluting stent carried a different drug: sirolimus, paclitaxel, everolimus or zotarolimus. The size of this reduction was different for each drug eluting stent. Sirolimus eluting stents worked much better than zotaro…
Abbott's next generation Xience Xpedition drug eluting stent receive CE Mark …pharmabiz.comAbbott's Xience Xpedition Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease. The company…
Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives …News-Medical.netAbbott (NYSE: ABT) today announced that the XIENCE Xpedition™ Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of …
InPharmGSK severe asthma drug progresses to Phase IIIInPharmThe year-long study, which involved 621 patients, found the number of clinically significant exacerbations in patients on GSK's drug – that is defined as episodes requiring oral corticos…
Abbott Reveals CE Mark Approval For XIENCE Xpedition Everolimus Eluting …NASDAQ(RTTNews.com) – Global health care company Abbott (ABT) Monday announced that its novel XIENCE Xpedition Everolimus Eluting Coronary Stent System for the treatment of coro…
Abbott reveals CE mark approval for XIENCE Xpedition Everolimus Eluting SystemRTT News8/20/2012 7:19 AM ET (RTTNews) – Global health care company Abbott (ABT:Quote) Monday announced that its novel XIENCE Xpedition Everolimus Eluting Coronary Stent Syst…
Telegraph.co.ukGlaxo's Experimental Drug Halves Asthma Attacks in StudyBusinessweekAmong 621 participants with severe asthma, after a year of treatment, the rate of attacks requiring oral corticosteroids, emergency room visits or hospitalizations w…
Zalicus: Preparing For A Q3 CatalystSeeking AlphaPrednisolone prevents the release of substances in the body that cause inflammation and is prescribed to treat a wide range of conditions including rheumatoid arthritis, allergic and respiratory disorder…
Telegraph.co.ukGSK drug halves attacks in hard-to-treat asthmaReuters India"It seems to be a safe and effective treatment option for patients with eosinophilic asthma that is associated with frequent flare-ups, and may reduce the need for conventi…